Company Description
Aravive (NASDAQ: ARAV) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.
ARAV stock has declined 100.0% over the past year.
This page provides a comprehensive overview of ARAV stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Aravive (ARAV) stock. Over the past 12 months, the stock has lost 100.0%.
Latest News
Aravive has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include clinical trial, conferences, earnings. View all ARAV news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ARAV Company Profile & Sector Positioning
Aravive (ARAV) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.